Design of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-Life
- 2 October 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 14 (10) , 1427-1433
Abstract
Diacylglycerol O-acyltransferase 2 (DGAT2) inhibitors have been shown to lower liver triglyceride content and are being explored clinically as a treatment for non-alcoholic steatohepatitis (NASH). This work details efforts to find an extended-half-life DGAT2 inhibitor. A basic moiety was added to a known inhibitor template, and the basicity and lipophilicity were fine-tuned by the addition of electrophilic fluorines. A weakly basic profile was required to find an appropriate balance of potency, clearance, and permeability. This work culminated in the discovery of PF-07202954 (12), a weakly basic DGAT2 inhibitor that has advanced to clinical studies. This molecule displays a higher volume of distribution and longer half-life in preclinical species, in keeping with its physicochemical profile, and lowers liver triglyceride content in a Western-diet-fed rat model.Keywords
This publication has 31 references indexed in Scilit:
- Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistanceTrends in Endocrinology & Metabolism, 2011
- Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid DeregulationJournal of Lipids, 2011
- Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net ReabsorptionDrug Metabolism and Disposition, 2011
- Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory CancerJournal of Medicinal Chemistry, 2008
- Knockdown of Acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in miceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine BasicitiesChemMedChem, 2007
- Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†Hepatology, 2005
- Physiologically Based Pharmacokinetic Modeling 1: Predicting the Tissue Distribution of Moderate-to-Strong BasesJournal of Pharmaceutical Sciences, 2005
- Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic ProfilesJournal of Medicinal Chemistry, 1999
- An improved method for the determination of distribution coefficientsJournal of Pharmacy and Pharmacology, 1990